Literature DB >> 9328573

Characterization of anti-human interleukin-18 (IL-18)/interferon-gamma-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA.

M Taniguchi1, K Nagaoka, T Kunikata, T Kayano, H Yamauchi, S Nakamura, M Ikeda, K Orita, M Kurimoto.   

Abstract

Interleukin-18 (IL-18)/interferon-gamma-inducing factor (IGIF) is a novel cytokine, which is a potent inducer of IFN-gamma production and plays an important role in Th1 responses. In order to develop a specific ELISA for the measurement of human IL-18, we established 13 anti-human IL-18 monoclonal antibodies and characterized them. 7 murine anti-human IL-18 mAbs and 6 rat anti-human IL-18 mAbs were obtained by fusion of splenocytes from mice or rats immunized with human IL-18, with SP2/0 myeloma cells. These antibodies were classified into 4 groups according to competitive binding ELISAs to the human IL-18 molecule. 1 murine mAb and all 6 rat mAbs neutralized IFN-gamma production induced by IL-18. A specific human IL-18 ELISA was developed using two neutralizing mAbs (#125-2H and #159-12B). This ELISA detects human IL-18 with a minimum detection limit of 10 pg/ml, but does not react with heat-denatured human IL-18. The ELISA does not show any cross-reactivity with other cytokines. Using this assay, human IL-18 was measurable in the plasma of leukemia patients. This ELISA would become a powerful tool for investigating the relationship between IL-18 and various diseases or analyzing the control mechanisms of IL-18 production from IL-18 producing cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9328573     DOI: 10.1016/s0022-1759(97)00094-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  12 in total

1.  Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis.

Authors:  T Yamano; T Higashi; K Nouso; H Nakatsukasa; K Kariyama; E Yumoto; Y Kobayashi; K Yamamoto; H Iwagaki; T Yagi; T Tanimoto; M Kurimoto; N Tanaka; T Tsuji
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  A synergistic role for IL-1beta and TNFalpha in monocyte-derived IFNgamma inducing activity.

Authors:  Raquel M Raices; Yashaswini Kannan; Anasuya Sarkar; Vedavathi Bellamkonda-Athmaram; Mark D Wewers
Journal:  Cytokine       Date:  2008-09-19       Impact factor: 3.861

3.  Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus.

Authors:  L D Giavedoni; M C Velasquillo; L M Parodi; G B Hubbard; V L Hodara
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Gene expression of interleukin 18 in unstimulated peripheral blood mononuclear cells of patients with alcoholic cirrhosis.

Authors:  C Hanck; T Manigold; U Böcker; M Kurimoto; C B Kölbel; M V Singer; S Rossol
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

5.  High IL-18 (interferon-gamma inducing factor) concentration in a purine nucleoside phosphorylase deficient patient.

Authors:  T Yamamoto; Y Moriwaki; K Matsui; S Takahashi; H Tsutsui; T Yoshimoto; H Okamura; K Nakanishi; Y Kurosawa; S Yamaguchi; Y Sasaki; K Higashino
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

6.  Elevation of IL-18 in human sepsis.

Authors:  S R Grobmyer; E Lin; S F Lowry; D E Rivadeneira; S Potter; P S Barie; C F Nathan
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

7.  Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells.

Authors:  M Miettinen; S Matikainen; J Vuopio-Varkila; J Pirhonen; K Varkila; M Kurimoto; I Julkunen
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients.

Authors:  U Coskun; N Gunel; B Sancak; E Onuk; M Bayram; A Cihan
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

9.  Novel methods to identify biologically relevant genes for leukemia and prostate cancer from gene expression profiles.

Authors:  Austin H Chen; Yin-Wu Tsau; Ching-Heng Lin
Journal:  BMC Genomics       Date:  2010-04-30       Impact factor: 3.969

10.  Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis.

Authors:  T Rooney; E Murphy; M Benito; P Roux-Lombard; O FitzGerald; J-M Dayer; B Bresnihan
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.